MEDICAL VETERINARY PHARMACEUTICAL PREPARATIONS
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| FACTORM | SANOFI | 46 avenue de la Grande Armée Paris 75017 France | medical and veterinary pharmaceutical preparations for use in stimulating and regulating growth; |
| FOX | Vectura GmbH | Robert-Koch-Allee 29 Gauting 82131 Germany | Medical and veterinary pharmaceutical preparations for use in inhalers and nebulizers for the prevention and treatment of, and protection against, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the prevention and treatment of and protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and medicated skin and tissue repair preparations; medical and veterinary pharmaceutical preparations for use in inhalers and nebulizers for the prevention and treatment of lung disease, lung infections and respiratory ailments; medical and veterinary pharmaceutical preparations and medicaments for use in inhalers and nebulizers for treating erectile dysfunction, premature ejaculation, female sexual dysfunction, chronic obstructive pulmonary disease, asthma, cystic fibrosis, migraine, and Parkinson's disease; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems; none of the aforementioned goods including medicated confectionary;Inhalers for medical purposes sold empty; metered dose inhalers for medical purposes sold empty; active dry powder inhalers for medical purposes sold empty; passive dry powder inhalers for medical purposes sold empty; nebulizers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods; |
| FOX | Vectura GmbH | Robert-Koch-Allee 29 Gauting 82131 Germany | Medical and veterinary pharmaceutical preparations for use in inhalers and nebulizers for the prevention and treatment of, and protection against, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the prevention and treatment of and protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and medicated skin and tissue repair preparations; medical and veterinary pharmaceutical preparations for use in inhalers and nebulizers for the prevention and treatment of lung disease, lung infections and respiratory ailments; medical and veterinary pharmaceutical preparations and medicaments for use in inhalers and nebulizers for treating erectile dysfunction, premature ejaculation, female sexual dysfunction, chronic obstructive pulmonary disease, asthma, cystic fibrosis, migraine, and Parkinson's disease; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems; none of the aforementioned goods including medicated confectionary;Inhalers for medical purposes sold empty; metered dose inhalers for medical purposes sold empty; active dry powder inhalers for medical purposes sold empty; passive dry powder inhalers for medical purposes sold empty; nebulizers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods; |
Where the owner name is not linked, that owner no longer owns the brand |
Technical Examples
- The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.